|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash reduction to the right-of-use asset | |||||
| Net amortization of investment premium and discount | |||||
| Impairment of operating right-of-use assets | |||||
| Impairment of long-lived assets | |||||
| Stock-based compensation | |||||
| Amortization of deferred commissions | |||||
| Realized and unrealized (gains) losses on equity securities | |||||
| Provision for doubtful accounts | |||||
| Value of shares of Class A common stock issued and donated to charity | |||||
| Share of losses from equity method investment | |||||
| Impairment of equity method investment | |||||
| Impairment of strategic investments | |||||
| Loss on net assets divested | |||||
| Loss on extinguishment of debt | |||||
| Other adjustments | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue and customer deposits | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Acquisitions, net of cash acquired and payments related to prior period acquisitions | |||||
| Divestitures, net of cash divested | |||||
| Purchases of marketable securities and other investments | |||||
| Proceeds from sales and maturities of marketable securities and other investments | |||||
| Capitalized software development costs | |||||
| Purchases of long-lived and intangible assets | |||||
| Net cash provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from public offerings, net of underwriters' discounts | |||||
| Payments of costs related to public offerings | |||||
| Proceeds from issuance of senior notes due 2029 and 2031, net of issuance costs | |||||
| Proceeds from settlements of capped call, net of settlement costs | |||||
| Principal payments on finance leases | |||||
| Value of equity awards withheld for tax liabilities | |||||
| Repurchases of shares of Class A common stock and related costs | |||||
| Proceeds from exercises of stock options and shares of Class A common stock issued under ESPP | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH —End of period | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest | |||||
| Value of common stock issued and equity awards assumed in acquisition | |||||
| Value of common stock issued to settle convertible senior notes due 2023 | |||||
| RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEETS | |||||
| Cash and cash equivalents | |||||
| Restricted cash in other current assets | |||||
| Restricted cash in other long-term assets | |||||
Loading...